Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults-Reference-Cited by-同舟云学术

Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults

Published:2024-02 Issue: Volume:170 Page:105622
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Prelog Martina,Jeske Samuel D.,Asam Claudia,Fuchs Andre,Wieser Andreas,Gall Christine,Wytopil Monika,Mueller-Schmucker Sandra M.,Beileke Stephanie,Goekkaya Mehmet,Kling Elisabeth,Geldmacher Christof,Rubio-Acero Raquel,Plank Michael,Christa Catharina,Willmann Annika,Vu Martin,Einhauser Sebastian,Weps Manuela,Lampl Benedikt M.J.,Almanzar Giovanni,Kousha Kimia,Schwägerl Valeria,Liebl Bernhard,Weber Beatrix,Drescher Johannes,Scheidt Jörg,Gefeller Olaf,Messmann Helmut,Protzer Ulrike,Liese Johannes,Hoelscher Michael,Wagner Ralf,Überla Klaus,Steininger Philipp

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference36 articles.

1. SARS-CoV-2 variant biology: immune escape, transmission and fitness;Carabelli;Nat. Rev. Microbiol.,2023

2. Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: a Population-Based Survey of 22 575 Participants;DeSantis;J. Infect. Dis.,2023

3. Monitoring des COVID-19-Impfgeschehens in Deutschland;Monatsbericht des RKI vom,2023

4. Wöchentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19);Wochenbericht vom,2023

5. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study;Menni;Lancet,2022